When Ozempic fails: Study sheds light on why some patients lose half as much weight as others
Researchers have used artificial intelligence to find out why some people have a better response to GLP-1 agonists
Stay updated with breaking news from Albert Lecube. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers have used artificial intelligence to find out why some people have a better response to GLP-1 agonists
The economic impact of obesity will reach losses of up to $4 trillion by 20235, or 3% of global GDP
Spain: Liraglutide may increase forced vital capacity (FVC) in type 2 diabetes patients, finds a recent study. This effect was shown to be linked to a significant decrease in circulating serum levels...
El alcalde de León, José Antonio Diez, ha firmado este lunes la adhesión de la ciudad de León a la 'Alianza de ciudades contra la obesidad', una iniciativa impulsada...